Truenat Receives EUA from DCGI for Nipah Virus Testing in India, Health News, ET Health World

New Delhi: Truenat This is the first kit I received in India Emergency use DCGI Approval for Implementation (EUA) Nipah virus test. This is a Molbio-based Goa-developed point-of-care real-time PCR platform used to detect the presence of viruses. diagnose..

Nipah virus (NiV), a zoonotic disease that has recurred in the Calicut district of Kerala, is hurting people and the health system as the state is already at stake. COVID Case. Signs and symptoms of fatal illness range from asymptomatic to acute respiratory infections and fatal encephalitis. Prior to the current reported cases from Calicut, India reported three previous NiV outbreaks (Siliguri in 2001 and Nadia (West Bengal) in 2007 and Calicut and Malaplum in Kerala in 2018. ).

The Truenat platform, which has gained attention over the past year, is a uniquely designed and manufactured, portable, battery-powered, IoT-enabled point of care. The platform can display results within an hour and has been used in the past to detect nearly 30 diseases including tuberculosis, COVID-19, dengue fever, chikungunya fever, hepatitis and HPV.

Learn more about the Truenat for Nipah development process testDr. Chandrasekhar Nair, Director and CTO of Molbio Diagnostics, said: During the outbreak situation. The ability to quickly deploy the platform where it is needed and the ability to quickly test it make it a powerful tool in diagnosing and containing Nipah viruses. “

DCGI approval of the truenat machine helps in the early diagnosis of illness for effective control and containment of viruses in the state. truenat

Back to top button